The effects of antioxidant 1 (ATOX1) knockdown, CuCl2, and DCAC50 knockdown on DLBCL cells and the activation of the mitogen-activated protein kinase (MAPK) pathway were investigated by conducting in vitro experiments. The gene discussed is ATOX1; the disease is diffuse large B-cell lymphoma.